Fragment-based drug discovery campaigns guided by native mass spectrometry
RSC Medicinal Chemistry · 2024 · 15 (7) · 2270-2285
DOI: 10.1039/d4md00273c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2024. Verfasst von Louise M Sternicki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Griffith Institute for Drug Discovery, Griffith University Nathan Brisbane Queensland 4111 Australia s.poulsen@griffith.edu.au. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ramaciotti Foundations, Australian Research Council.
Abstract (Originalsprache)
Native mass spectrometry (nMS) is well established as a biophysical technique for characterising biomolecules and their interactions with endogenous or investigational small molecule ligands such as fragments.
Autor:innen und Institutionen
- Griffith Institute for Drug Discovery, Griffith University Nathan Brisbane Queensland 4111 Australia s.poulsen@griffith.edu.au.
- ARC Centre for Fragment-Based Design Australia.
ORCID-Profile: Louise M Sternicki, Sally-Ann Poulsen
Förderung
- Ramaciotti Foundations
- Australian Research Council
Zitieren
APA
Sternicki, L. M., & Poulsen, S. A. (2024). Fragment-based drug discovery campaigns guided by native mass spectrometry. RSC Medicinal Chemistry, 15(7), 2270-2285. https://doi.org/10.1039/d4md00273c
Vancouver
Sternicki LM, Poulsen SA. Fragment-based drug discovery campaigns guided by native mass spectrometry. RSC Medicinal Chemistry. 2024;15(7):2270-2285. doi:10.1039/d4md00273c
BibTeX
@article{Sternicki2024,
author = {Sternicki, Louise M and Poulsen, Sally-Ann},
title = {Fragment-based drug discovery campaigns guided by native mass spectrometry},
journal = {RSC Medicinal Chemistry},
year = {2024},
volume = {15},
number = {7},
pages = {2270--2285},
doi = {10.1039/d4md00273c}
}
EUVIMED